Safwan appointed by Boehringer Ingelheim as new distributor for Kuwait
AAW partners with global pharma manufacturer
KUWAIT CITY, Dec 25: Safwan Trading & Contracting Co, a subsidiary of Ali Abdulwahab Al Mutawa Commercial Co. (AAW), announced today it was appointed by Boehringer Ingelheim (BI), one of the world’s leading pharmaceutical companies, as its exclusive distributor for the Kuwait market.
The agreement was signed at AAW headquarters in a ceremony attended by Safwan and BI representatives, including AAW Chairman and CEO Faisal Ali Al Mutawa, Safwan COO Officer Dr Dina Younan, Safwan Pharma Manager Dr Tony Gerges, Safwan Regulatory, PV and Tenders Manager Dr Absullah Al-Enezi, BI General Manager & Head of Human Pharma of GulfIP Mazen Bachir, BI National Sales Manager Hany El Kasaby.
AAW Chairman and CEO Faisal
Ali Al Mutawa, said: “We are honored to be partnering with an international and world-renowned company like Boehringer Ingelheim. This partnership enables us to further develop the pharmaceutical sector in Kuwait and continue to provide the market with new medical and pharmaceutical products.”
General Manager & Head of Human Pharma of GulfIP Mazen Bachir, said: “Through our partnership with Safwan Trading & Contracting we are strengthening BI’s position towards better serving our customers and all of Kuwait’s residents. This is also in line with the country’s national programme designed to ensure the continued provision of quality healthcare with the support of the private sector. We are very proud of our local teams who have worked relentlessly towards a smooth transition, laying the foundations for a bright future ahead of our organization. We are privileged to have the opportunity to support Kuwait towards delivering its social commitment to provide top-notch universal healthcare”.
Safwan Trading & Contracting Co is one of the top leading companies in Kuwait in the health care business, representing a considerable number of wellknown multinational principals. Safwan has been in business since 1967 and is recognized as a major supplier of pharmaceuticals, medical equipment and supplies, and laboratory products; from the health care sector to the Ministry of Health & other ministries, as well as public and private institutions. In 2005, Safwan was placed as the first company in its category to be enlisted in the Kuwait Stock Exchange.